Analysis: In China’s Medical Beauty Business, Only the Fittest Now Survive

Intensified regulation has left China’s once-hot medical beauty industry primed for a shake-up that looks likely to favor companies whose core technologies and products comply with the new rules.

An era of “strong regulation” began for China’s medical beauty companies in 2021, a year when watchdogs issued more than 20 new regulations designed to stamp out violations in the industry, Liu Wenzheng, an analyst at Minsheng Securities Co. Ltd. said in a March research report.